Pegcetacoplan versus Eculizumab in PNH
N Engl J Med
.
2021 Oct 28;385(18):1723-1724.
doi: 10.1056/NEJMc2106424.
Authors
Yasutaka Ueda
1
,
Hiroyuki Takamori
1
,
Jun-Ichi Nishimura
1
Affiliation
1
Osaka University Graduate School of Medicine, Osaka, Japan junnishi@bldon.med.osaka-u.ac.jp.
PMID:
34706182
DOI:
10.1056/NEJMc2106424
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized* / therapeutic use
Hemoglobinuria, Paroxysmal* / drug therapy
Humans
Substances
Antibodies, Monoclonal, Humanized
eculizumab